Fibronectin-Alginate microcapsules improve cell viability and protein secretion of encapsulated Factor IX-engineered human mesenchymal stromal cells

References

• Bolton-Maggs PH, Pasi KJ. 2003. Haemophilias A and B. Lancet. 361:1801–1809.
   PubMed Web of Science ®Google Scholar
• Chang PL, Hortelano G, Awrey DE, Tse M. 1994. Growth of recombinant fibroblasts in alginate microcapsules. Biotechnol Bioeng. 43:925–933.
   PubMed Web of Science ®Google Scholar
• Chang TM. 1964. Semipermeable microcapsules. Science. 146: 524–525.
   PubMed Web of Science ®Google Scholar
• Chang TMS. 2005. Therapeutic applications of polymeric artificial cells. Nat Rev Drug Discov. 4:221–235.
   PubMed Web of Science ®Google Scholar
• Check E. 2003. Harmful potential of viral vectors fuels doubts over gene therapy. Nature. 423:573–574.
   PubMed Web of Science ®Google Scholar
• Cieslinski DA, David Humes H. 1994. Tissue engineering of a bioartificial kidney. Biotechnol Bioeng. 43:678–681.
   PubMed Web of Science ®Google Scholar
• Dolatshahi-Pirouz A, Jensen TH, Kolind K, Bünger C, Kassem M, Foss M, Besenbacher F. 2011. Cell shape and spreading of stromal (mesenchymal) stem cells cultured on fibronectin coated gold and hydroxyapatite surfaces. Colloids Surf B Biointerfaces. 84:18–25.
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 8:315–317.
   PubMed Web of Science ®Google Scholar
• Goren A, Dahan N, Goren E, Baruch L, Machluf M. 2010. Encapsulated human mesenchymal stem cells: a unique hypoimmunogenic platform for long-term cellular therapy. FASEB J. 24:22–31.
   PubMed Web of Science ®Google Scholar
• Hortelano G, Al-Hendy A, Ofosu FA, Chang PL. 1996. Delivery of human factor IX in mice by encapsulated recombinant myoblasts: a novel approach towards allogeneic gene therapy of hemophilia B. Blood. 87:5095–5103.
   PubMed Web of Science ®Google Scholar
• Hortelano G, Xu N, Vandenberg A, Solera J, Chang PL, Ofosu FA. 1999. Persistent delivery of factor IX in mice: gene therapy for hemophilia using implantable microcapsules. Hum Gene Ther. 10:1281–1288.
   PubMed Web of Science ®Google Scholar
• Hortelano G, Wang L, Xu N, Ofosu FA. 2001. Sustained and therapeutic delivery of factor IX in nude haemophilia B mice by encapsulated C2C12 myoblasts: concurrent tumourigenesis. Haemophilia. 7:207–214.
   PubMed Web of Science ®Google Scholar
• Karoubi G, Ormiston ML, Stewart DJ, Courtman DW. 2009. Single-cell hydrogel encapsulation for enhanced survival of human marrow stromal cells. Biomaterials. 30:5445–5455.
   PubMed Web of Science ®Google Scholar
• Kilian KA, Bugarija B, Lahn BT, Mrksich M. 2010. Geometric cues for directing the differentiation of mesenchymal stem cells. Proc Natl Acad Sci USA. 107:4872–4877.
   PubMed Web of Science ®Google Scholar
• Koo J, Chang TM. 1993. Secretion of erythropoietin from microencapsulated rat kidney cells: preliminary results. Int J Artif Organs. 16:557–560.
   PubMed Web of Science ®Google Scholar
• Lim F, Sun AM. 1980. Microencapsulated islets as bioartificial endocrine pancreas. Science. 210:908–910.
   PubMed Web of Science ®Google Scholar
• Marshall, E. 2001. Gene therapy. Panel reviews risks of germ line changes.Science. 294:2268–2269.
   Web of Science ®Google Scholar
• McBeath R, Pirone DM, Nelson CM, Bhadriraju K, Chen CS. 2004. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell. 6:483–495.
   PubMed Web of Science ®Google Scholar
• Nathwani AC, Tuddenham EG, Rangarajan S, Rosales C, McIntosh J, Linch DC, et al. 2011. Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med. 365:2357–2365.
   PubMed Web of Science ®Google Scholar
• Orive G, Hernández RM, Gascón AR, Calafiore R, Chang TM, De Vos P, et al. 2003. Cell encapsulation: promise and progress. Nat Med. 9:104–107.
   PubMed Web of Science ®Google Scholar
• Orive G, Hernández RM, Rodríguez Gascón A, Calafiore R, Chang TM, de Vos P, et al. 2004. History, challenges and perspectives of cell microencapsulation. Trends Biotechnol. 22:87–93.
   PubMed Web of Science ®Google Scholar
• Orive G, De Castro M, Kong HJ, Hernández RM, Ponce S, Mooney DJ, Pedraz JL. 2009. Bioactive cell-hydrogel microcapsules for cell-based drug delivery. J Control Release. 135:203–210.
   PubMed Web of Science ®Google Scholar
• Rebelatto CK, Aguiar AM, Moretão MP, Senegaglia AC, Hansen P, Barchiki F, et al. 2008. Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Exp Biol Med (Maywood). 233:901–913.
   PubMed Web of Science ®Google Scholar
• Sadler J, Davie E. 1987. The metabolic basis of inherited disease. In Hemophilia A, hemophilia B, and von Willebrand's disease. New York: W.B. Saunders. pp. 575–598.
   Google Scholar
• Sayyar B, Dodd M, Wen J, Ma S, Marquez-Curtis L, Janowska-Wieczorek A, Hortelano G. 2012. Encapsulation of factor IX–engineered mesenchymal stem cells in fibrinogen–alginate microcapsules enhances their viability and transgene secretion. J Tissue Eng [online]. 3:2041731412462018. Available at: http://www.tej.sagepub.com/content/3/1/2041731412462018.long. Accessed on December 5 2013.
   Google Scholar
• Sayyar B, Dodd M, Marquez-Curtis L, Janowska-Wieczorek A, Hortelano G. 2013. Cell-matrix interactions of Factor IX (FIX)- engineered human mesenchymal stromal cells encapsulated in RGD-alginate vs. fibrinogen-alginate microcapsules. Artif Cells Nanomed Biotechnol [online]. E-pub ahead of print. Available at: http://www.informahealthcare.com/doi/abs/10.3109/21691401.2013.794354. Accessed on December 5 2013.
   Google Scholar
• Schoen FJ, Mitchell RN 1996. Biomaterials Science: An Introduction to Materials in Medicine. San Diego: Academic Press.
   Google Scholar
• Shin H, Jo S, Mikos AG. 2003. Biomimetic materials for tissue engineering. Biomaterials. 24:4353–4364.
   PubMed Web of Science ®Google Scholar
• Son BR, Marquez-Curtis LA, Kucia M, Wysoczynski M, Turner AR, Ratajczak J, et al. 2006. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells. 24: 1254–1264.
   PubMed Web of Science ®Google Scholar
• Stupack DG, Cheresh DA. 2002. Get a ligand, get a life: integrins, signaling and cell survival. J Cell Sci. 115:3729–3738.
   PubMed Web of Science ®Google Scholar
• Thakur A, Sengupta R, Matsui H, Lillicrap D, Jones K, Hortelano G. 2010. Characterization of viability and proliferation of alginate-poly-L-lysine-alginate encapsulated myoblasts using flow cytometry. J Biomed Mater Res Part B Appl Biomater. 94: 296–304.
   PubMed Web of Science ®Google Scholar
• Wen J, Xu N, Li A, Bourgeois J, Ofosu FA, Hortelano G. 2007. Encapsulated human primary myoblasts deliver functional hFIX in hemophilic mice. J Gene Med. 9:1002–1010.
   PubMed Web of Science ®Google Scholar
• Wen J, Vargas AG, Ofosu FA, Hortelano G. 2006. Sustained and therapeutic levels of human factor IX in hemophilia B mice implanted with microcapsules: key role of encapsulated cells. J Gene Med. 8:362–369.
   PubMed Web of Science ®Google Scholar
• Whitlock BB, Gardai S, Fadok V, Bratton D, Henson PM. 2000. Differential roles for alpha(M)beta(2) integrin clustering or activation in the control of apoptosis via regulation of akt and ERK survival mechanisms. J Cell Biol. 151:1305–1320.
   PubMed Web of Science ®Google Scholar
• Zvibel I, Smets F, Soriano H. 2002. Anoikis: roadblock to cell transplantation? Cell Transplant. 11:621–630.
   PubMed Web of Science ®Google Scholar